Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.

The oncologist

Volumn 13 Suppl 1, Issue , 2008, Pages 1-4

  Bunn Jr , Paul A ^a   Thatcher, Nick ^a  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN KINASE INHIBITOR;

CANCER STAGING; DRUG EFFECT; EDITORIAL; GENE EXPRESSION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; PATHOLOGY; PROTO ONCOGENE; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION; GENES, ERBB-1; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROTEIN KINASE INHIBITORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 42049112092     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (0)